AgriBusiness Investments & Funding Round Partnerships

Lavie Bio Latest News: Extend Biofungicide Validation Trials With Bayer Ag

Lavie Bio, an Evogene subsidiary, has received the final $2.5 million from Corteva, advancing sustainable bio-fungicide development.

Key Takeaways:

  • Lavie Bio Ltd., an ag-biologicals company and subsidiary of Evogene Ltd., in collaboration with Bayer AG, extends its biofungicide validation trials following successful initial tests.
  • The first-year laboratory and greenhouse tests demonstrated the effectiveness of Lavie Bio’s biofungicides against critical diseases impacting fruits and vegetables globally.
  • The partnership moves into a second year of field validation trials, indicating positive progress and potential for innovative agricultural solutions.

Lavie Bio Ltd., a pioneer in the development of microbiome-based, computational-driven bio-stimulant and bio-pesticide products, has announced an extension of its joint validation trials for biofungicides with Bayer AG, a leading global entity in the agriculture sector. This decision comes on the heels of a successful first-year of laboratory and greenhouse testing, which showcased the potential of Lavie Bio’s biofungicides in combating diseases that pose significant threats to fruits and vegetables worldwide. The promising outcomes have paved the way for a second year of validation trials, this time in field experiments, marking a significant step in the product’s development journey.

A Leap Forward in Agri-Biological Innovation

Benoit Hartmann, Head of Biologics at Bayer Crop Science, emphasized the importance of this collaboration in Bayer’s innovation strategy, stating, “Biofungicides are a real opportunity for innovation, and we are looking forward to the new solutions this partnership with Lavie Bio helps us deliver together.” This extension underscores the commitment of both companies to explore and deliver new biological solutions that can enhance agricultural productivity and sustainability.

Amit Noam, CEO of Lavie Bio, expressed enthusiasm over the progression to field trials, remarking on the importance of this milestone for the company and its implications for global agriculture. “This not only highlights the immense business potential of our product and its meaningful impact on farmers worldwide but also reinforces our dedication to collaborative partnerships within the industry as we work together to deliver innovative solutions to the market.”


Lavie Bio Latest News

Partners With Ceres Global Ag Corp. To Promote Regenerative Agriculture (2024/03/14)

Lavie Bio Ltd. and Ceres Global Ag Corp. have teamed up to integrate Lavie Bio’s YalosTM bio-inoculant into Ceres’ sustainability and regenerative agriculture initiatives across North America. This collaboration reflects a shared vision to advance sustainable agricultural practices, with Ceres committed to regenerative agriculture to combat climate change. Lavie Bio aims to transform the crop input sector by developing biological alternatives to traditional synthetic products. Ceres’ decision to include YalosTM in its 2024 crop-year program highlights a commitment to innovation and support for regenerative agricultural practices.

Secures $2.5M Payment from Corteva (2024/02/29)

Lavie Bio Ltd. has completed a pivotal financial agreement with Corteva, marking a crucial step in advancing sustainable agricultural technologies. Lavie Bio’s bio-fungicide products, born from their BDD technology platform, are aimed at critical agricultural issues. Following the initial $2.5 million payment, Lavie Bio secured the remaining $5 million. The partnership with Corteva sets the stage for future financial gains and showcases the power of combining advanced computational biology with practical agricultural needs.

Strategic Partnership with WinField United Canada (2023/12/06)

Lavie Bio has partnered with WinField United Canada for the exclusive distribution of their bio-inoculant seed treatment, Yalos™. This partnership is aimed at expanding the company’s presence in key regions of Canada – Saskatchewan, Alberta, and Manitoba. Yalos™ has proven to be a game-changer in agriculture, showing a notable yield increase in wheat, durum, and barley. Lavie Bio utilizes advanced computational predictive platforms and AI technologies to develop novel bio-inoculants and bio-pesticides for sustainable agricultural productivity. WinField United Canada is Canada’s leading agricultural distributor.

Expands Yalos™ to Durum and Barley (2023/11/29)

Lavie Bio Ltd., a subsidiary of Evogene Ltd., has expanded its flagship product, Yalos™, to include durum wheat and barley, after successful field trials in 2023. Yalos™ is a seed treatment solution that optimizes soil nutrients, reduces the impact of environmental stress, and increases crop yields. The expansion significantly increases Yalos™’s addressable market in the US and Canada by ~40%. The company plans to continue its commercial growth and innovation trajectory by expanding to additional crops in the United States, Canada, and other regions.

Lavie Bio and Corteva Enter Licensing Agreement (2023/07/18)

Lavie Bio and Corteva have partnered to bring innovative microbiome-based ag-biological products to farmers globally. The company’s BDD platform, powered by Evogene’s MicroBoost AI tech engine, uses big data, artificial intelligence, and advanced informatics to develop bio-stimulant and bio-pesticide products. Corteva’s market leadership and scale-up capabilities complement the company’s expertise. This partnership aims to provide effective, environmentally friendly, and sustainable solutions to combat agricultural challenges like fruit rots and powdery mildew.

Lavie Bio’s Thrivus™ Receives Regulatory Approval in Canada (2023/05/25)

Lavie has received regulatory approval from the Canadian Food Inspection Agency for its bio-inoculant seed treatment, Thrivus™. The product enhances the production of Hard Red Spring Wheat, improving the availability and efficiency of soil nutrients while mitigating environmental stresses. Thrivus™ has already demonstrated its efficacy during the 2022 growing season in the United States, with an average yield increase of 3-4 bushels per acre and delivering a 4x return on investment for farmers. The company plans to expand the application of Thrivus™ beyond Spring Wheat to other crops such as barley, durum, oats, and other field crops in the coming year.

Image provided by Lavie Bio

2 Comments

Leave a Reply

X

Discover more from iGrow News

Subscribe now to keep reading and get access to the full archive.

Continue reading